Using biomimetic molecular recognition as the core means, and combining with nanotechnology, advanced materials, separation science, biological mass spectrometry and Raman spectroscopy, we aim to develop novel methods and materials for biological separation, -omics analysis, disease diagnosis, single cell analysis, cancer targeted therapy and cancer immunotherapy.

1. Biomimetic molecular recognition (boronate affinity recognition, molecular imprinting, aptamer selection);

2. Biological separation and -omics analysis;

3. Disease diagnosis;

4. Single cell analysis;

5. Cancer targeted therapy and cancer immunotherapy.